Author
Listed:
- Matteo Crosera
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy
Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via Giorgeri 1, Trieste 34127, Italy)
- Andrea Prodi
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy
These authors contributed equally to this work.)
- Marcella Mauro
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy
These authors contributed equally to this work.)
- Marco Pelin
(Department of Life Sciences, University of Trieste, Via L. Giorgeri 7/9, Trieste 34127, Italy)
- Chiara Florio
(Department of Life Sciences, University of Trieste, Via L. Giorgeri 7/9, Trieste 34127, Italy)
- Francesca Bellomo
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy)
- Gianpiero Adami
(Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via Giorgeri 1, Trieste 34127, Italy)
- Pietro Apostoli
(Dipartimento di Specialità Medico Chirurgiche, Scienze Radiologiche, Sanità Pubblica, University of Brescia, Piazza del Mercato 15, Brescia 25121, Italy)
- Giuseppe De Palma
(Dipartimento di Specialità Medico Chirurgiche, Scienze Radiologiche, Sanità Pubblica, University of Brescia, Piazza del Mercato 15, Brescia 25121, Italy)
- Massimo Bovenzi
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy)
- Marco Campanini
(IMEM-CNR Institute, Parco Area delle Scienze 37/A, Parma 43124, Italy)
- Francesca Larese Filon
(Clinical Unit of Occupational Medicine, Department of Medical Sciences, University of Trieste, Via della Pietà 19, Trieste 34129, Italy)
Abstract
Titanium dioxide nanoparticles (TiO 2 NPs) suspensions (concentration 1.0 g/L) in synthetic sweat solution were applied on Franz cells for 24 h using intact and needle-abraded human skin. Titanium content into skin and receiving phases was determined. Cytotoxicity (MTT, AlamarBlue ® and propidium iodide, PI, uptake assays) was evaluated on HaCat keratinocytes after 24 h, 48 h, and seven days of exposure. After 24 h of exposure, no titanium was detectable in receiving solutions for both intact and damaged skin. Titanium was found in the epidermal layer after 24 h of exposure (0.47 ± 0.33 μg/cm 2 ) while in the dermal layer, the concentration was below the limit of detection. Damaged skin, in its whole, has shown a similar concentration (0.53 ± 0.26 μg/cm 2 ). Cytotoxicity studies on HaCaT cells demonstrated that TiO 2 NPs induced cytotoxic effects only at very high concentrations, reducing cell viability after seven days of exposure with EC 50 s of 8.8 × 10 −4 M (MTT assay), 3.8 × 10 −5 M (AlamarBlue ® assay), and 7.6 × 10 −4 M (PI uptake, index of a necrotic cell death). Our study demonstrated that TiO 2 NPs cannot permeate intact and damaged skin and can be found only in the stratum corneum and epidermis. Moreover, the low cytotoxic effect observed on human HaCaT keratinocytes suggests that these nano-compounds have a potential toxic effect at the skin level only after long-term exposure.
Suggested Citation
Matteo Crosera & Andrea Prodi & Marcella Mauro & Marco Pelin & Chiara Florio & Francesca Bellomo & Gianpiero Adami & Pietro Apostoli & Giuseppe De Palma & Massimo Bovenzi & Marco Campanini & Francesca, 2015.
"Titanium Dioxide Nanoparticle Penetration into the Skin and Effects on HaCaT Cells,"
IJERPH, MDPI, vol. 12(8), pages 1-16, August.
Handle:
RePEc:gam:jijerp:v:12:y:2015:i:8:p:9282-9297:d:53897
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:12:y:2015:i:8:p:9282-9297:d:53897. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.